|
Originally published In Press as doi:10.1074/jbc.M605117200 on November 3, 2006
J. Biol. Chem., Vol. 282, Issue 1, 65-71, January 5, 2007
The Role of the Ubiquitin Ligase E6-AP in Human Papillomavirus E6-mediated Degradation of PDZ Domain-containing Proteins*
Petric Kuballa,
Konstantin Matentzoglu, and
Martin Scheffner1
From the
Department of Biology, University of Konstanz, 78457 Konstanz, Germany
The E6 oncoprotein of human papillomaviruses associated with cervical cancer targets the tumor suppressor p53 and several other cellular proteins including the human homologs of Dlg and Scribble for degradation via the ubiquitin-proteasome system. Similar to p53 degradation, E6-induced degradation of Scribble is mediated by the ubiquitin ligase E6-AP. In contrast, degradation of Dlg in vitro and within cells has been reported to be independent of E6-AP, suggesting that the E6 oncoprotein has the ability to interact with ubiquitin ligases other than E6-AP. Furthermore, the ability of the E6 oncoprotein to interact with these yet unidentified ubiquitin ligases may be shared by the E6 protein of so-called low risk human papillomaviruses that are not associated with cervical cancer. In this study, we used the RNA interference technology and mouse embryo fibroblasts derived from E6-AP-deficient mice to obtain information about the identity of the ubiquitin ligase(s) involved in E6-mediated degradation of Dlg. We report that, within cells, E6-mediated degradation of Dlg depends on the presence of functional E6-AP and provide evidence that the E6 protein of low risk human papillomaviruses functionally interacts with E6-AP. Based on these data, we propose that, in general, the proteolytic properties of human papillomavirus E6 proteins are mediated by interaction with E6-AP.
Received for publication, May 30, 2006
, and in revised form, October 18, 2006.
* This work was supported by the Center of Molecular Medicine Cologne. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 13.
1 To whom correspondence should be addressed: Dept. of Biology, Box M642, University of Konstanz, 78457 Konstanz, Germany. Tel.: 49-7531-885150; Fax: 49-7531-885162; E-mail: martin.scheffner{at}uni-konstanz.de.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. Lin, M. Bazzaro, M.-C. Wang, K. C. Chan, S. Peng, and R. B.S. Roden
Combination of Proteasome and HDAC Inhibitors for Uterine Cervical Cancer Treatment
Clin. Cancer Res.,
January 15, 2009;
15(2):
570 - 577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Cooper, N. Brimer, and S. B. Vande Pol
Human Papillomavirus E6 Regulates the Cytoskeleton Dynamics of Keratinocytes through Targeted Degradation of p53
J. Virol.,
November 15, 2007;
81(22):
12675 - 12679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Topffer, A. Muller-Schiffmann, K. Matentzoglu, M. Scheffner, and G. Steger
Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses
J. Gen. Virol.,
November 1, 2007;
88(11):
2956 - 2965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mazroui, S. Di Marco, R. J. Kaufman, and I.-E. Gallouzi
Inhibition of the Ubiquitin-Proteasome System Induces Stress Granule Formation
Mol. Biol. Cell,
July 1, 2007;
18(7):
2603 - 2618.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|